Fifty-four out of 100 mass-forming type CCA (MF-CCA) patient specimens (54%) revealed high cytoplasmic immunostaining for MALT1 (H score ≥120, Figure 5A). The gene discussed is MALT1; the disease is cholangiocarcinoma.